Page last updated: 2024-08-17

quinoxalines and Iris Diseases

quinoxalines has been researched along with Iris Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lugo, E; Méndez-Cepeda, P; Sevillano, C; Viso, E	1
Faulkner, W	1

Other Studies

2 other study(ies) available for quinoxalines and Iris Diseases

Article	Year
[Iris microhaemangiomas: presentation of a case]. Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:2 Topics: Administration, Topical; Aged; Brimonidine Tartrate; Cyclopentolate; Dexamethasone; Diabetes Mellitus, Type 2; Female; Glaucoma, Open-Angle; Hamartoma; Humans; Hyphema; Iris Diseases; Latanoprost; Microscopy, Acoustic; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Vision Disorders	2014
Miotic effect of alphagan P. Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:3 Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris Diseases; Pupil; Quinoxalines	2003

Article

Year

[Iris microhaemangiomas: presentation of a case].

Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:2

Topics: Administration, Topical; Aged; Brimonidine Tartrate; Cyclopentolate; Dexamethasone; Diabetes Mellitus, Type 2; Female; Glaucoma, Open-Angle; Hamartoma; Humans; Hyphema; Iris Diseases; Latanoprost; Microscopy, Acoustic; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Vision Disorders

2014

Miotic effect of alphagan P.

Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:3

Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris Diseases; Pupil; Quinoxalines

2003